Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Clinics in Laboratory Medicine
|
June 2, 2010
Tick-borne flaviviruses
P Rocco Lasala, Michael Holbrook
Plos Pathogens
|
June 6, 2013
Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine
Joseph E Blaney, Andrea Marzi, Mallory Willet, et al.
Science Translational Medicine
|
April 15, 2026
The virus entry inhibitor ARN-75039 provides therapeutic protection against Lassa virus infection in guinea pigs
Elizabeth Eudy, Daniel Woodburn, Rebecca Reeder, et al.
Transfusion
|
September 12, 2021
How do I… facilitate a rapid response to a public health emergency requiring plasma collection with a public-private partnership?
Maureen J Miller, Adam Skrzekut, Ian Kracalik, et al.
Emerging Infectious Diseases
|
November 4, 2008
Framework for leadership and training of Biosafety Level 4 laboratory workers
James W Le Duc, Kevin Anderson, Marshall E Bloom, et al.
Frontiers in Immunology
|
October 3, 2022
Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2
Yun Ji, Qi Zhang, Lin Cheng, et al.
Research Square
|
January 10, 2024
Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membrane
Erica Saphire, Zhe Li Salie, Zunlong Ke, et al.
Science Translational Medicine
|
September 14, 2021
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
Hyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Biorxiv : the Preprint Server for Biology
|
April 6, 2021
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants
Hyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Clinics in Laboratory Medicine
|
June 2, 2010
Tick-borne flaviviruses
P Rocco Lasala, Michael Holbrook
Plos Pathogens
|
June 6, 2013
Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine
Joseph E Blaney, Andrea Marzi, Mallory Willet, et al.
Science Translational Medicine
|
April 15, 2026
The virus entry inhibitor ARN-75039 provides therapeutic protection against Lassa virus infection in guinea pigs
Elizabeth Eudy, Daniel Woodburn, Rebecca Reeder, et al.
Transfusion
|
September 12, 2021
How do I… facilitate a rapid response to a public health emergency requiring plasma collection with a public-private partnership?
Maureen J Miller, Adam Skrzekut, Ian Kracalik, et al.
Emerging Infectious Diseases
|
November 4, 2008
Framework for leadership and training of Biosafety Level 4 laboratory workers
James W Le Duc, Kevin Anderson, Marshall E Bloom, et al.
Frontiers in Immunology
|
October 3, 2022
Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2
Yun Ji, Qi Zhang, Lin Cheng, et al.
Research Square
|
January 10, 2024
Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membrane
Erica Saphire, Zhe Li Salie, Zunlong Ke, et al.
Science Translational Medicine
|
September 14, 2021
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
Hyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Biorxiv : the Preprint Server for Biology
|
April 6, 2021
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants
Hyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, et al.
Page
of 1